Front Row Advisors’s Organon & Co OGN Stock Holding History

Front Row Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35	Buy	+3	New	+$36	﹤0.01%	569
2026 Q1	–	Sell	-3	Closed	-$18	–	565
2025 Q4	$18	Hold	3	–	–	﹤0.01%	547
2025 Q3	$27	Hold	3	–	–	﹤0.01%	546
2025 Q2	$25	Hold	3	–	–	﹤0.01%	530
2025 Q1	$47	Hold	3	–	–	﹤0.01%	504
2024 Q4	$47	Hold	3	–	–	﹤0.01%	494
2024 Q3	$61	Sell	3 -10	-77%	-$207	﹤0.01%	492
2024 Q2	$273	Hold	13	–	–	﹤0.01%	918
2024 Q1	$248	Buy	13 +10	+333%	+$172	﹤0.01%	903
2023 Q4	$46	Sell	3 -10	-77%	-$136	﹤0.01%	468
2023 Q3	$229	Hold	13	–	–	﹤0.01%	899
2023 Q2	$0	Hold	13	–	–	﹤0.01%	929
2023 Q1	$0	Buy	13 +3	+30%	+$81	﹤0.01%	937
2022 Q4	$0	Buy	+10	New	+$256	﹤0.01%	922
2022 Q2	–	Sell	-29	Closed	-$1K	–	942
2022 Q1	$1K	Hold	29	–	–	﹤0.01%	911
2021 Q4	$1K	Buy	29 +16	+123%	+$521	﹤0.01%	924
2021 Q3	$0	Hold	13	–	–	﹤0.01%	954
2021 Q2	$0	Buy	+13	New	+$428	﹤0.01%	971

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Front Row Advisors's OGN Position: Q2 2026 in Review

Front Row Advisors opened a new position in Organon & Co (OGN) in Q2 2026: 3 shares worth $35. The stake represents ﹤0.01% of the portfolio and ranks #569 among its holdings. This is a return to the name: Front Row Advisors previously reported a position in OGN as recently as Q4 2025.

Front Row Advisors first reported a position in OGN in Q2 2021 and has held it in 18 quarters since. The position peaked at $1K in Q1 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Front Row Advisors held 3 shares of Organon & Co worth $35 as of Q2 2026.
Organon & Co was a new Front Row Advisors position in Q2 2026.
Organon & Co made up ﹤0.01% of Front Row Advisors's portfolio in Q2 2026, its #569 holding.
Front Row Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 18 quarters since.
Front Row Advisors's Organon & Co position peaked at $1K in Q1 2022.
631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Front Row Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.